KIF18A inhibitor (Satyarx)

N/A

Report date: 2025/03/20 15:06:36
NME

Base Information

Drug NameKIF18A inhibitor (Satyarx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSatyarx Pharma Innovations Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSatyarx Pharma Innovations Pvt Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A